Technical Analysis for AGIO - Agios Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade C 65.17 0.51% 0.33
AGIO closed up 0.51 percent on Tuesday, March 19, 2019, on 75 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Up Up
See historical AGIO trend table...

Date Alert Name Type % Chg
Mar 15 180 Bullish Setup Bullish Swing Setup 0.25%
Mar 15 Pocket Pivot Bullish Swing Setup 0.25%
Mar 15 Inside Day Range Contraction 0.25%
Mar 13 Up 3 Days in a Row Strength -1.14%
Mar 8 MACD Bearish Signal Line Cross Bearish 5.37%
Mar 8 1,2,3 Pullback Bullish Bullish Swing Setup 5.37%
Mar 8 Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 5.37%
Mar 8 Narrow Range Bar Range Contraction 5.37%
Mar 8 NR7 Range Contraction 5.37%
Mar 8 Wide Bands Range Expansion 5.37%

Older signals for AGIO ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Agios Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics in the field of cancer metabolism and inborn errors of metabolism (IEMs) in the United States. Its products include AG-221, an oral inhibitor of the mutated isocitrate dehydrogenase (IDH) 2 protein for the treatment of patients with cancers that harbor IDH2 mutations, as well as for the Type II D-2 hydroxyglutaric aciduria treatment; AG-120, an oral inhibitor of the mutated IDH1 protein for the treatment of patients with cancers that harbor IDH1 mutations; and enzyme glutaminase that converts the nutrient glutamine into the metabolite glutamate. The company's products also comprise AG-348, an oral small molecule activator of PKR enzyme for the treatment of patients with pyruvate kinase deficiency. It has a collaboration agreement with Celgene Corporation. The company was founded in 2007 and is based in Cambridge, Massachusetts.
Chemistry Biopharmaceutical Cancer Cancers Organic Chemistry Inborn Errors Of Metabolism Agios Pharmaceuticals
Is AGIO a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 99.82
52 Week Low 41.63
Average Volume 491,910
200-Day Moving Average 69.7043
50-Day Moving Average 57.9078
20-Day Moving Average 63.613
10-Day Moving Average 64.138
Average True Range 2.5903
ADX 37.9
+DI 27.3946
-DI 11.4683
Chandelier Exit (Long, 3 ATRs ) 61.1691
Chandelier Exit (Short, 3 ATRs ) 63.3309
Upper Bollinger Band 69.588
Lower Bollinger Band 57.638
Percent B (%b) 0.63
BandWidth 18.785468
MACD Line 2.1308
MACD Signal Line 2.4063
MACD Histogram -0.2755
Fundamentals Value
Market Cap 3.16 Billion
Num Shares 48.4 Million
EPS -6.33
Price-to-Earnings (P/E) Ratio -10.30
Price-to-Sales 59.19
Price-to-Book 6.21
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 68.77
Resistance 3 (R3) 68.87 67.78 68.17
Resistance 2 (R2) 67.78 66.86 67.73 67.97
Resistance 1 (R1) 66.47 66.29 65.93 66.37 67.77
Pivot Point 65.38 65.38 65.10 65.33 65.38
Support 1 (S1) 64.07 64.46 63.53 63.97 62.57
Support 2 (S2) 62.98 63.89 62.93 62.37
Support 3 (S3) 61.67 62.98 62.17
Support 4 (S4) 61.57